The ESC-HF Pilot survey demonstrates that acute HF retains a poor prognosis, whereas evidence-based treatments have improved outcomes in chronic HF, with notable regional variations across Europe.
The ESC-HF Pilot survey confirmed that acute HF is still associated with a very poor medium-term prognosis, while the widespread adoption of evidence-based treatments in patients with chronic HF seems to have improved their outcome profile. Differences across countries may be due to different local medical practice as well to differences in healthcare systems. This pilot study also offered the opportunity to refine the organizational structure for a long-term extended European network.
Maggioni et al. (Thu,) studied this question.